30 Day Trial


Founded in 1992, ORTHOWORLD® is the only provider of strategic intelligence in the world solely focused on the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.

Highly specialized product offerings such as ORTHOWORLD Membership, ORTHOFLASH®, market reports, ORTHOPRENEUR®, BONEZONE® and OMTEC® empower industry participants to respond to challenges, maximize opportunities and more aggressively expand their orthopaedic businesses. We welcome the opportunity to assist you.


  • 4:45 p.m. OrthoSpace closed a US $7MM equity financing round. Funds will support an ongoing U.S. IDE study and ex-U.S. commercialization for the InSpacerotator cuff repair balloon.
  • 1:30 p.m. Independent study results indicate comparable clinical outcomes with the use of generic vs. conventional orthopaedic trauma implants, with savings averaging US $1,197 per case. Generic implants were provided by The Orthopaedic Implant Company.
Read More

Articles of Interest All Articles

Headcount Reductions, New Appointments at Biologics and Spine Companies

Updates from Alphatec, Amedica, Carmell and Xtant Medical as they seek to support regulatory clearance and product commercialization.